# EDGAR Filing Document

**Accession Number:** 0001783875
**File Stem:** 0001279569-25-000595
**Filing Date:** 2025-6
**Character Count:** 4197
**Document Hash:** fde9f15fee4b5b523b25b66118f45c46
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001279569-25-000595.hdr.sgml**: 20250610

**ACCESSION NUMBER**: 0001279569-25-000595

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250609

**ITEM INFORMATION**: Bankruptcy or Receivership

**FILED AS OF DATE**: 20250610

**DATE AS OF CHANGE**: 20250610

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** 4Front Ventures Corp.
- **CENTRAL INDEX KEY:** 0001783875
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 834168417
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56075
- **FILM NUMBER:** 251038203

**BUSINESS ADDRESS:**
- **STREET 1:** 7010 E. CHAUNCEY LANE STE. 235
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85054
- **BUSINESS PHONE:** (602) 633-3067

**MAIL ADDRESS:**
- **STREET 1:** 7010 E. CHAUNCEY LANE STE. 235
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85054

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): June 10, 2025 (June 9, 2025)**

**4FRONT VENTURES CORP.**

**(Exact name of registrant as specified in its charter}**

---

| | | |
|:---|:---|:---|
| **<u>British Columbia</u>** | **<u>000-56075</u>** | **<u>83-4168417</u>** |
| **(State or Other Jurisdiction**<br> **of Incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

**11811 N. Tatum Blvd., Suite 3031**

**<u>Phoenix, Arizona 85028</u>**

**(Address of principal executive offices including zip code)**

**<u>(602) 428-5337</u>**

**(Registrant's telephone number including area code)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(g) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Subordinate Voting Shares, no par value | FFNTF | OTC Pink Markets |
|  | FFNT | CSE |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

| | |
|:---|:---|
| **Item 1.03.** | **Bankruptcy or Receivership.** |

---

On June 9, 2025, 4Front Ventures Corp. made an assignment pursuant to the Canadian Bankruptcy and Insolvency Act. The proceeding, titled *In the Matter of the Bankruptcy of 4Front Ventures Corp.*, case number 11-3233771, was filed in the District of British Columbia, Vancouver Division. On June 10, 2025, B. Riley Farber Inc. was appointed trustee over the Company's assets.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **4FRONT** | **VENTURES CORP.** |
| Date: June 10, 2025 | | /s/ Andrew Thut |
|  |  | Andrew Thut |
|  |  | Chief Executive Officer |

---